Regimens Comparison for Breast Cancers of Positive Lymph Nodes
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Epirubicin, CTX, Paclitaxel|DRUG: Epirubicin, Paclitaxel
Sponsor: Chinese Academy of Medical Sciences